News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32647)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
2 (165)
3 (175)
4 (151)
5 (147)
6 (92)
9 (206)
10 (178)
11 (131)
12 (134)
13 (90)
16 (130)
17 (134)
18 (124)
19 (139)
20 (123)
23 (88)
27 (84)
30 (66)
31 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
27
30
31
Drug Development
NOXXON Pharma AG Release: Interim Phase 2a Results For Spiegelmer® Olaptesed Pegol (NOX-A12) In CLL And MM Studies
December 9, 2013
·
1 min read
Business
Charles River Laboratories (Massachusetts) Announces Organizational Changes To Enhance Global Capabilities
December 9, 2013
·
1 min read
Policy
Baxter International, Inc. Files For Pediatric Indication Of RIXUBIS [Coagulation Factor IX (Recombinant)] Treatment For Hemophilia B In The United States
December 9, 2013
·
1 min read
Drug Development
Sunovion Pharmaceuticals Inc. Presents Phase 3 Pooled Analysis Of Once-Daily Aptiom® (Eslicarbazepine Acetate) As Adjunctive Treatment For Partial-Onset Seizures
December 9, 2013
·
1 min read
Drug Development
Senesco Technologies, Inc. Announces Results Of Cohort 3 In SNS01-T Phase 1b/2a Trial
December 9, 2013
·
1 min read
Infinity Pharmaceuticals Inc. Reports Updated Phase 1 Data Of IPI-145 In Indolent Non-Hodgkin Lymphoma At American Society of Hematology Annual Meeting
December 9, 2013
·
1 min read
First Analysis Of Extended Dosing With Celgene International Sárl Epigenetic Agent CC-486 In Patients With Higher-Risk Myelodysplastic Syndromes Presented At American Society of Hematology
December 9, 2013
·
1 min read
Genetown
Foundation Medicine, Inc. Release: FoundationOne™ Heme Enables Identification Of Genomic Alterations Not Identified By Conventional Methods Across Hematologic Malignancies
December 9, 2013
·
1 min read
Genetown
PHT Corporation Provides Web-Based Data Collection System For Eclinical Trials Via Apple Ipad®
December 9, 2013
·
1 min read
Drug Development
NOXXON Pharma AG Release: Interim Phase IIa Results For Spiegelmer Olaptesed Pegol (NOX-A12) In CLL And MM Studies
December 9, 2013
·
7 min read
Previous
16 of 21
Next
